RT Journal Article
SR Electronic
T1 Monitoring the opioid epidemic via social media discussions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.01.21254815
DO 10.1101/2021.04.01.21254815
A1 Lavertu, Adam
A1 Hamamsy, Tymor
A1 Altman, Russ B
YR 2021
UL http://medrxiv.org/content/early/2021/04/07/2021.04.01.21254815.abstract
AB The opioid epidemic persists in the United States; in 2019, annual drug overdose deaths increased by 4.6% to 70,980, including 50,042 opioid-related deaths. The widespread abuse of opioids across geographies and demographics and the rapidly changing dynamics of abuse require reliable and timely information to monitor and address the crisis. Social media platforms include petabytes of participant-generated data, some of which, offers a window into the relationship between individuals and their use of drugs. We assessed the utility of Reddit data for public health surveillance, with a focus on the opioid epidemic. We built a natural language processing pipeline to identify opioid-related comments and created a cohort of 1,689,039 geo-located Reddit users, each assigned to a city and state. We followed these users over a period of 10+ years and measured their opioid-related activity over time. We benchmarked the activity of this cohort against CDC overdose death rates for different drug classes and NFLIS drug report rates. Our Reddit-derived rates of opioid discussion strongly correlated with external benchmarks on the national, regional, and city level. During the period of our study, kratom emerged as an active discussion topic; we analyzed mentions of kratom to understand the dynamics of its use. We also examined changes in opioid discussions during the COVID-19 pandemic; in 2020, many opioid classes showed marked increases in discussion patterns. Our work suggests the complementary utility of social media as a part of public health surveillance activities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementA.L. is supported by a National Science Foundation Graduate Research Fellowship (DGE - 1656518). T.H. is supported by NIH R01DK103358, Simons Foundation, NSF - IOS-1546218, R35GM122515, NSF CBET - 1728858 and NIH R01AI130945. R.B.A. is supported by NIH GM102365, HG010615, and the Chan-Zuckerberg Biohub.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research did not require IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe underlying data is not provided for ethical reasons.